@curator

1 year ago

Article

Fierce Pharma Asia—Daiichi loses Seagen patent suit; CDMO builds $500M gene therapy plant; Legend lands on SEC warning list

Rating: 0.0

Likes: 1

Library: 1

Fierce Pharma Asia—Daiichi loses Seagen patent suit; CDMO builds $500M gene therapy plant; Legend lands on SEC warning list

Daiichi Sankyo was ordered to pay Seagen $42 million in their antibody-drug conjugate patent lawsuit. Gene therapy delivery CDMO VectorBuilder will build a $500 million campus in China. | Daiichi Sankyo lost to Seagen in the first found of a patent battle. A U.S. gene therapy delivery CDMO will build a $500 million campus in China. Legend Biotech is the latest Chinese firm flagged by U.S. securities authorities for audit law violations. And more.

Rate This Post

Rate The Educational Value

Rate The Ease of Understanding and Presentation

Interesting or Boring? Rate the Entertainment Value

Fierce Pharma Asia—Daiichi loses Seagen patent suit; CDMO builds $500M gene therapy plant; Legend lands on SEC warning list

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge
for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge
for Humanity's Progress

Fierce Pharma Asia—Daiichi loses Seagen patent suit; CDMO builds $500M gene therapy plant; Legend lands on SEC warning list

Rate This Post

Related Topics

Comments

Media:

My Account:

Boostlane:

Select a Category

Topics Trending Today

Recommended Media

Boostlane Reward System

Unlocking the Power of Knowledge for Humanity's Progress

Quick Links

Select a Locale

Unlocking the Power of Knowledge for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress

Unlocking the Power of Knowledge
for Humanity's Progress